Bicycle Therapeutics Priced Its Public Offering Of 9.4M American Depositary Shares, Each Representing One Ordinary Share, At $21.25 Per Share, For Gross Proceeds Of Approximately $200M
Portfolio Pulse from Benzinga Newsdesk
Bicycle Therapeutics has priced its public offering of 9.4 million American Depositary Shares (ADS), each representing one ordinary share, at $21.25 per share. This will result in gross proceeds of approximately $200 million.
July 13, 2023 | 8:48 am
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Bicycle Therapeutics' public offering of 9.4 million ADS at $21.25 per share could impact its stock price.
The public offering could lead to a dilution of shares, which may put downward pressure on the stock price. However, the proceeds from the offering could be used to fund growth initiatives, which could have a positive impact on the company's future prospects.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100